345 top medical experts on Multiple Hamartoma Syndrome across 38 countries and 25 U.S. states, including 290 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Multiple Hamartoma Syndrome: A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Facial trichilemmomas and papillomatous papules of the oral mucosa are the most characteristic lesions. Individuals with this syndrome have a high risk of breast cancer; thyroid cancer; and endometrial cancer. This syndrome is associated with mutations in the gene for pten phosphatase.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Multiple Primary Neoplasms (1,921), Hamartoma (963), Hereditary Neoplastic Syndromes (1,050) and Narrower Categories: Proteus Syndrome (262).
  4. Clinical Trials ClinicalTrials.gov : at least 8 including 1 Active, 3 Completed, 4 Recruiting
  5. Synonyms: Bannayan-Riley-Ruvalcaba Syndrome, Cowden Disease, Cowden's Disease, Lhermitte-Duclos Disease, PTEN Hamartoma Tumor Syndrome


  

        

                    


    Computing Expert Listing ...

);